Shenqi Fuzheng injection alleviates chemotherapy-induced cachexia by restoring glucocorticoid signaling in hypothalamus

doi: 10.1016/j.jpha.2023.08.015

• Entezar Berik^a,b , 
• Zijia Zhang^b,c , 
• Wei Li^b,c , 
• Yawen Liu^b,c , 
• Sihan Chen^b,c , 
• Wenyong Wu^b,d , 
• Zhaojun Wang^b,c , 
• Xinqin Kong^b,c , 
• Wenqiang Pei^b,d , 
• Huiqing Dong^b,d , 
• Huali Long^b,c , 
• Min Lei^b,c , 
• Jennifer Yiyang Wang^b , 
• Liangfeng Liu^e,f , 
• Jinjun Hou^b,c , 
• Jing Feng^{c,g ,  ,}  , 
• Zhaoxia Li^{a ,  ,}  , 
• Wanying Wu^{b,c ,  ,}  , 
• De-an Guo^b,c

• a. Beijing Key Lab of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China;

• b. National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China;

• c. University of Chinese Academy of Sciences, Beijing, 100049, China;

• d. School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210029, China;

• e. Limin Pharmaceutical Factory, Livzon Group Limited, Shaoguan, Guangdong, 512028, China;

• f. Guangdong Corporate Key Laboratory of High-End Liquid Medicine R&D, Industrilization, Shaoguan, Guangdong, 512028, China;

• g. Center for Neurological and Psychiatric Research and Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai, 201203, China